https://www.ionchannellibrary.com/news/research/structure-of-the-cardiac-sodium-channel/2022-11-12T14:29:23+00:00https://www.ionchannellibrary.com/news/industry/integral-molecular-announces-lead-p2x7-antibodies/2022-11-12T06:42:03+00:00https://www.ionchannellibrary.com/news/industry/newron-announced-new-clinical-trial-with-evenamide/2022-11-12T06:41:54+00:00https://www.ionchannellibrary.com/blog/extraordinary-ordinary-patch-clamp/2023-02-16T10:19:09+00:00https://www.ionchannellibrary.com/blog/10-key-nature-papers/2023-02-16T10:19:34+00:00https://www.ionchannellibrary.com/news/industry/metrion-lifearc-collaboration/2022-11-12T06:42:16+00:00https://www.ionchannellibrary.com/careers/who-what-and-why-of-ionchannellibrary/2023-03-07T13:44:20+00:00https://www.ionchannellibrary.com/analytics/ion-channel-publication-trends/2022-11-03T06:40:21+00:00https://www.ionchannellibrary.com/infographics/permeability-of-lipid-bilayers-infographic/2020-01-19T14:38:45+00:00https://www.ionchannellibrary.com/infographics/electrical-signals-infographic/2020-05-31T21:16:47+00:00https://www.ionchannellibrary.com/fundamentals/nobel-prizes/2022-11-03T08:20:40+00:00https://www.ionchannellibrary.com/infographics/membrane-transport-infographic/2020-01-19T14:45:03+00:00https://www.ionchannellibrary.com/fundamentals/history-of-ion-channels/2022-11-03T07:10:32+00:00https://www.ionchannellibrary.com/fundamentals/why-we-should-care-about-ion-channels/2022-11-19T07:17:28+00:00https://www.ionchannellibrary.com/fundamentals/membrane-transport/2022-11-03T07:02:55+00:00https://www.ionchannellibrary.com/fundamentals/what-are-ion-channels/2022-11-03T11:22:04+00:00https://www.ionchannellibrary.com/news/industry/cadent-therapeutics-announced-fda-acceptance-of-sk-channel-modulator/2022-11-12T06:41:22+00:00https://www.ionchannellibrary.com/analytics/ion-channel-journal-trends/2023-02-16T08:50:18+00:00https://www.ionchannellibrary.com/news/industry/coda-biotherapeutics-acquires-attenua-and-three-clinical-stage-assets/2022-11-12T06:41:13+00:00https://www.ionchannellibrary.com/news/industry/vertex-has-discontinued-its-nav1-8-inhibitor-vx-961/2022-11-12T06:41:17+00:00https://www.ionchannellibrary.com/analytics/top-ion-channel-friendly-journals/2022-11-03T06:30:37+00:00https://www.ionchannellibrary.com/news/industry/ligand-pharmaceuticals-will-acquire-core-assets-from-icagen/2022-11-12T06:41:09+00:00https://www.ionchannellibrary.com/analytics/how-many-ion-channel-scientists-are-there/2022-11-03T06:42:04+00:00https://www.ionchannellibrary.com/analytics/trends-in-ion-channel-paper-authorship/2022-11-19T07:25:14+00:00https://www.ionchannellibrary.com/news/industry/merck-announces-positive-results-from-gefapixant-trials/2022-11-12T06:40:57+00:00https://www.ionchannellibrary.com/news/industry/redpin-therapeutics-has-raised-15m-to-advance-its-ion-channel-based-chemogenetics-platform/2022-11-12T06:40:53+00:00https://www.ionchannellibrary.com/news/industry/saniona-enters-into-second-collaboration-agreement-with-boehringer-ingelheim-in-schizophrenia/2022-11-12T06:40:48+00:00https://www.ionchannellibrary.com/interviews/hugues-abriel/2022-11-23T18:00:43+00:00https://www.ionchannellibrary.com/interviews/damian-bell/2022-11-23T17:58:02+00:00https://www.ionchannellibrary.com/blog/what-is-an-ion/2023-02-16T10:20:04+00:00https://www.ionchannellibrary.com/interviews/andrea-meredith-on-bk-channelopathies/2022-11-23T17:56:11+00:00https://www.ionchannellibrary.com/blog/what-is-a-channel/2023-02-16T10:19:54+00:00https://www.ionchannellibrary.com/interviews/lucie-delemotte-on-ion-channel-simulations/2022-11-23T17:51:47+00:00https://www.ionchannellibrary.com/blog/crowdfunding-scientific-research/2023-02-16T11:23:22+00:00https://www.ionchannellibrary.com/news/industry/praxis-advances-ion-channel-portfolio/2022-11-12T06:40:38+00:00https://www.ionchannellibrary.com/news/industry/coda-collaborates-with-the-facial-pain-research-foundation/2022-11-12T06:40:34+00:00http://kavliprize.org/prizes-and-laureates/prizes/2020-kavli-prize-neuroscience2022-11-12T14:13:10+00:00https://www.ionchannellibrary.com/news/industry/ligand-expanded-icagens-collaboration-with-roche/2022-11-12T06:40:16+00:00https://www.ionchannellibrary.com/news/industry/engrail-therapeutics-raises-32-million-to-develop-neuroscience-therapeutics/2022-11-12T06:40:12+00:00https://www.ionchannellibrary.com/news/industry/nmd-pharma-clinical-trial-clc-1-channel-inhibitor-myasthenia-gravis/2022-11-12T06:39:59+00:00https://www.ionchannellibrary.com/news/industry/bellus-health-reports-topline-results-from-its-phase-2-trial-of-blu-5937-for-chronic-cough/2022-11-12T06:40:03+00:00https://www.ionchannellibrary.com/news/industry/calcimedica-crac-inhibitor-auxora-shows-promise-as-a-treatment-for-severe-covid-19-pneumonia/2022-11-12T06:39:54+00:00https://www.ionchannellibrary.com/news/industry/praxis-has-raised-110m-to-advance-its-ion-channel-drugs/2022-11-12T06:39:40+00:00https://www.ionchannellibrary.com/news/industry/calcimedica-collaborating-with-epipharma-on-crac-channel-inhibitor-drugs/2022-11-12T06:39:44+00:00https://www.ionchannellibrary.com/news/industry/autifony-therapeutics-initiates-a-phase-1-study-of-kv3-modulator/2022-11-12T06:40:43+00:00https://www.ionchannellibrary.com/news/industry/calcimedica-raises-15-million-to-support-clinical-trials-in-patients-with-covid-19-pneumonia/2022-11-12T06:40:30+00:00https://www.ionchannellibrary.com/news/industry/kineta-is-about-to-initiate-phase-1-clinical-trials-of-nachr-antagonist-for-the-treatment-of-chronic-neuropathic-pain/2022-11-12T06:39:36+00:00https://www.ionchannellibrary.com/interviews/chris-mathes-on-the-automated-patch-clamp/2022-11-23T17:47:54+00:00https://www.ionchannellibrary.com/news/industry/enterprise-therapeutics-initiates-a-phase-1-study-of-its-tmem16a-potentiator-for-the-treatment-of-cystic-fibrosis/2022-11-12T06:39:31+00:00https://www.ionchannellibrary.com/news/industry/asana-biosciences-phase-1b-trials-sodium-channel-blocker-for-pruritus-in-atopic-dermatitis/2022-11-12T06:41:02+00:00https://www.ionchannellibrary.com/news/industry/goldfinch-bio-has-raised-100m-to-advance-its-trpc5-inhibitor-and-cb1-inverse-agonist-for-the-treatment-of-kidney-diseases/2022-11-12T06:40:07+00:00https://www.ionchannellibrary.com/news/industry/fda-approved-qutenza-capsaicin-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy/2022-11-12T06:39:49+00:00https://www.ionchannellibrary.com/interviews/fredrik-elinder-on-ion-channels-in-sweden/2022-11-23T17:50:14+00:00https://www.ionchannellibrary.com/news/industry/acadia-pharmaceuticals-acquires-cersci-therapeutics/2022-11-12T06:39:23+00:00https://www.ionchannellibrary.com/news/industry/nocion-initiated-phase-1-clinical-trial-of-charged-sodium-channel-blocker-for-the-treatment-of-cough/2022-11-12T06:39:18+00:00https://www.ionchannellibrary.com/news/industry/vistagen-positive-results-from-second-preclinical-study-of-an-nmdar-antagonist/2022-11-12T06:39:14+00:00https://www.ionchannellibrary.com/news/industry/casma-therapeutics-has-raised-50-million-to-advance-its-trpml1-agonist-for-muscular-dystrophy/2022-11-12T06:39:10+00:00https://www.ionchannellibrary.com/news/industry/algiax-pharmaceuticals-enrolls-patients-in-a-phase2a-study-evaluating-gabaa-receptor-modulator-in-chronic-neuropathic-pain/2022-11-12T06:39:05+00:00https://www.ionchannellibrary.com/news/industry/sophion-bioscience-strengthens-its-team-by-appointing-damian-bell-as-director-of-scientific-affairs/2022-11-12T06:39:00+00:00https://www.ionchannellibrary.com/news/industry/selection-secures-5m-promissory-note-to-advance-its-kv1-3-selective-peptide-blocker-into-clinical-development/2022-11-12T06:38:55+00:00https://www.ionchannellibrary.com/news/industry/nmd-pharma-clinical-trial-of-clc-1-channel-inhibitor-nmd670-for-symptoms-of-myasthenia-gravis/2022-11-12T06:38:51+00:00https://www.ionchannellibrary.com/news/industry/enterprise-therapeutics-tmem16a-potentiator-program-acquired-by-roche/2022-11-12T06:38:46+00:00https://www.ionchannellibrary.com/news/industry/kineta-and-genentech-extended-collaboration-to-develop-nachr-antagonist-for-the-treatment-of-chronic-pain/2022-11-12T06:38:41+00:00https://www.ionchannellibrary.com/news/industry/knopp-biosciences-has-entered-the-second-year-of-the-nih-funded-research-to-discover-non-opioid-treatments-for-chronic-pain/2022-11-12T06:38:36+00:00https://www.ionchannellibrary.com/news/industry/daewoong-pharmaceutical-spins-off-its-ion-channel-rd-unit-into-a-new-company-in-therapeutics/2022-11-12T06:38:32+00:00https://www.ionchannellibrary.com/interviews/thomas-binzer-on-automated-patch-clamp-and-building-bridges-with-academia/2022-11-23T17:44:30+00:00https://www.ionchannellibrary.com/news/research/outstanding-ion-channel-scientists-receive-honorary-awards/2022-11-12T14:19:49+00:00https://www.ionchannellibrary.com/news/industry/metrion-biosciences-and-grunenthal-group-extended-their-ion-channel-drug-discovery-collaboration/2022-11-12T06:38:27+00:00https://www.ionchannellibrary.com/interviews/lesley-anson-on-scientific-publishing/2022-11-23T17:32:17+00:00https://www.ionchannellibrary.com/news/industry/saniona-regains-gabaa5-program-from-boehringer-ingelheim/2022-11-12T06:38:15+00:00https://www.ionchannellibrary.com/news/industry/caraway-therapeutics-receives-research-grant-to-study-the-role-of-tmem175-in-parkinsons-disease/2022-11-12T06:38:10+00:00https://www.ionchannellibrary.com/interviews/andrea-bruggemann-on-automated-patch-clamp/2022-11-23T17:38:58+00:00https://www.ionchannellibrary.com/news/industry/cadent-therapeutics-and-its-ion-channel-programs-to-be-acquired-by-novartis/2022-11-12T06:37:51+00:00https://www.ionchannellibrary.com/news/industry/ligands-icagen-and-gsk-enter-collaboration-and-license-agreement-to-target-neurological-disorders/2022-11-12T06:37:10+00:00https://www.ionchannellibrary.com/news/industry/soricimed-to-investigate-the-potential-benefit-of-its-trpv6-inhibitor-sor-c13-in-the-treatment-of-covid-19/2022-11-12T06:37:44+00:00https://www.ionchannellibrary.com/news/industry/tetragenetics-announces-discovery-of-functional-antibodies-against-nav1-8/2022-11-12T06:38:00+00:00https://www.ionchannellibrary.com/news/industry/quralis-selective-kcnq2-3-opener-demonstrates-increased-potency-and-reduction-in-side-effects-compared-to-retigabine/2022-11-12T06:38:05+00:00https://www.ionchannellibrary.com/news/industry/kineta-initiates-phase-1-clinical-trial-of-its-nachr-antagonist-kcp506-for-the-treatment-of-chronic-pain/2022-11-12T06:37:55+00:00https://www.ionchannellibrary.com/news/industry/fda-approves-vertexs-trikafta-symdeko-and-kalydeco-for-use-in-people-with-cystic-fibrosis-with-certain-rare-mutations/2022-11-12T06:37:04+00:00https://calcimedica.com/2021/03/11/calcimedica-announces-21-million-series-d-financing/2022-11-12T15:31:44+00:00https://www.metrionbiosciences.com/metrion-biosciences-closes-2-7m-new-equity-financing/2022-11-12T15:32:28+00:00https://investors.soleno.life/news-releases/news-release-details/soleno-therapeutics-announces-collaboration-vanderbilt2022-11-12T15:33:29+00:00https://investors.aeriepharma.com/news-releases/news-release-details/aerie-pharmaceuticals-completes-enrollment-its-phase-2b-clinical2022-11-12T15:26:54+00:00https://www.ionchannellibrary.com/interviews/irina-vetter-on-pain-stinging-trees-and-ion-channels-in-australia/2022-11-23T17:34:49+00:00https://carawaytx.com/caraway-therapeutics-establishes-collaboration-with-abbvie-to-develop-novel-small-molecule-therapeutics-for-parkinsons-disease-and-other-related-disorders/2022-11-12T15:27:41+00:00https://www.metrionbiosciences.com/metrion-biosciences-and-bioqube-ventures-collaborate-on-venture-creation-project-to-identify-novel-ion-channel-inhibitors-for-autoimmune-diseases/2022-11-12T15:28:04+00:00https://www.newron.com/news-and-media/regulatory-news/newron-presents-encouraging-interim-results-evenamide-patients2022-11-12T14:45:50+00:00https://carawaytx.com/caraway-therapeutics-expands-scientific-advisory-board-with-the-appointment-of-david-clapham-md-phd/2022-11-12T15:19:18+00:00https://investor.ligand.com/press-releases/detail/456/ligand-and-gsk-expand-global-collaboration-and-license2022-11-12T15:21:44+00:00https://munatherapeutics.com/muna-therapeutics-awarded-4-9m-grant-from-the-michael-j-fox-foundation-for-parkinsons-research-supports-development-of-disease-modifying-therapy-for-parkinsons-disease/2022-11-12T12:22:42+00:00https://sophion.com/sussex-drug-discovery-centre-and-sophion-bioscience-announce-new-strategic-partnership/2022-11-12T12:15:10+00:00https://news.saniona.com/news-releases/news-release-details/saniona-reports-positive-top-line-results-san711-phase-12022-11-12T14:42:03+00:00https://news.saniona.com/news-releases/news-release-details/sanionas-anti-inflammatory-and-anti-fibrotic-candidate-san9032022-11-23T13:43:28+00:00https://news.saniona.com/news-releases/news-release-details/saniona-initiates-phase-1-clinical-trial-san7112022-11-12T15:23:35+00:00https://sophion.com/products/qpatch-compact/2022-11-12T15:20:34+00:00https://www.metrionbiosciences.com/metrion-biosciences-appoints-dr-benedetta-montagnini-as-head-of-european-business-development/2022-11-13T05:31:39+00:00https://med.uth.edu/blog/2022/07/13/researchers-discover-novel-light-gated-potassium-channel/2022-11-12T11:42:17+00:00https://www.metrionbiosciences.com/metrion-biosciences-expands-ion-channel-drug-discovery-service-capabilities-and-in-house-expertise/2022-11-13T04:54:22+00:00https://www.metrionbiosciences.com/metrion-biosciences-appoints-rory-curtis-as-vice-president-us-commercial-operations/2022-11-13T05:02:46+00:00https://www.metrionbiosciences.com/metrion-biosciences-expands-into-new-headquarters-to-support-continued-growth/2022-11-13T05:07:40+00:00https://www.metrionbiosciences.com/metrion-biosciences-appoints-nick-foster-as-chief-commercial-officer-and-head-of-global-business-development/2022-11-13T05:32:01+00:00https://www.metrionbiosciences.com/metrion-biosciences-appoints-mark-keogh-as-non-executive-director/2022-11-13T05:30:51+00:00https://www.metrionbiosciences.com/metrion-biosciences-appoints-john-montana-as-non-executive-director/2022-11-13T05:45:13+00:00https://www.metrionbiosciences.com/metrion-biosciences-and-sosei-heptares-to-explore-structure-based-drug-discovery-sbdd-approaches-to-ion-channels-through-strategic-technology-collaboratio/2022-11-13T05:44:23+00:00https://sophion.com/sophion-and-genedata-announces-integration-of-qpatch-ii-and-qube-384-data-to-genedata-screener/2022-11-13T05:59:48+00:00https://www.nanion.de/en/news/news-a-press/8211-10-10-2022-adult-mammalian-cardiomyocytes-successfully-recorded-for-the-first-time-on-a-high-throughput-automated-patch-clamp-instrument.html2022-11-13T06:21:21+00:00https://www.nanion.de/en/news/news-a-press/7002-07-07-2021-launch-of-the-syncropatch-384-for-all-your-patch-clamp-needs.html2022-11-13T07:26:52+00:00https://www.nanion.de/en/news/news-a-press/7733-10-03-2022-the-syncropatch-384-is-installed-at-the-fda-for-cardiac-safety-pharmacology-studies.html2022-11-13T07:34:13+00:00https://www.nanion.de/en/news/news-a-press/8062-27-07-2022-its-coming-home-the-syncropatch-384-is-installed-in-goettingen-the-birthplace-of-patch-clamp.html2022-11-13T07:47:09+00:00https://www.nanion.de/en/news/news-a-press/5018-17-04-2020-nanion-technologies-and-nexel-partner-to-open-a-new-reference-demonstration-laboratory-in-south-korea.html2022-11-13T08:14:09+00:00https://calcimedica.com/2022/01/20/calcimedica-initiates-cardea-plus-a-clinical-trial-of-auxoratm-in-patients-with-critical-covid-19-pneumonia/2022-11-13T08:24:05+00:00https://www.nmdpharma.com/news/nmd670-top-line-data2022-11-13T09:52:34+00:00https://www.nmdpharma.com/news/oddfornmd6702022-11-13T09:58:38+00:00https://www.nmdpharma.com/news/jorgequiroz2022-11-13T14:45:48+00:00https://www.nmdpharma.com/news/usoffice2022-11-13T10:08:16+00:00https://www.nmdpharma.com/news/new-investor2022-11-13T10:13:21+00:00https://investors.aeriepharma.com/news-releases/news-release-details/alcon-acquire-aerie-pharmaceuticals-inc-enhancing-its-ophthalmic2022-11-13T10:29:46+00:00https://investors.aeriepharma.com/news-releases/news-release-details/aerie-pharmaceuticals-announces-first-participant-dosed-comet-32022-11-13T10:37:24+00:00https://investors.aeriepharma.com/news-releases/news-release-details/aerie-pharmaceuticals-announces-first-participant-dosed-phase-32022-11-13T10:41:09+00:00https://www.fiercebiotech.com/research/breaking-vicious-itch-scratch-cycle-targeting-miswired-neurons2022-11-13T11:16:23+00:00https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-biohaven-pharmaceuticals2022-11-13T13:36:28+00:00https://axalbion.com/2022/06/29/axalbion-announces-positive/2022-11-13T14:08:35+00:00https://axalbion.com/2021/10/20/axalbion-announces-clinical/2022-11-13T14:26:43+00:00https://www.businesswire.com/news/home/20220130005011/en/Juvenescence-Ltd.-Portfolio-Company-Hails-Successful-Limb-Regeneration-in-Adult-Frogs2022-11-13T14:42:52+00:00https://ir.biohaven.com/news-releases/news-release-details/biohaven-sets-new-course-258-million-cash-proven-team-and-deep2022-11-13T14:58:08+00:00https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-subsidiary-napo-pharmaceuticals-announces2022-11-13T15:14:07+00:00https://www.bridgebiorx.com/en/board/board.php?bo_table=news_en&idx=322022-11-13T16:15:10+00:00https://www.fiercebiotech.com/research/gene-therapy-inspired-by-bacteria-shows-promise-for-heart-rhythm-diseases2022-11-13T16:56:12+00:00https://news.cuanschutz.edu/news-stories/cu-anschutz-researchers-identify-a-new-mechanism-responsible-for-controlling-auditory-sensitivity2022-11-14T03:35:23+00:00https://news.mit.edu/2021/neurons-humans-mammals-11102022-11-14T03:52:15+00:00https://news.mit.edu/2022/how-neurons-build-maintain-capacity-to-communicate-07212022-11-14T04:06:27+00:00https://news.mit.edu/2020/chemists-discover-structure-key-coronavirus-protein-11122022-11-14T04:14:32+00:00https://www.hopkinsmedicine.org/news/newsroom/news-releases/blocking-an-ion-channel-improves-muscle-function-and-survival-in-mice-with-severe-duchenne-muscular-dystrophy2022-11-14T04:23:43+00:00https://www.hopkinsmedicine.org/news/newsroom/news-releases/study-identifies-potential-new-treatment-target-for-sleep-apnea2022-11-14T04:35:00+00:00https://www.stjude.org/media-resources/news-releases/2022-medicine-science-news/a-surprising-inactivation-mechanism-for-a-voltage-gated-ion-channel.html2022-11-14T04:50:46+00:00https://www.titech.ac.jp/english/news/2022/0645162022-11-14T05:02:25+00:00https://news.weill.cornell.edu/news/2022/11/pacemaker-channel-discovery-could-lead-to-better-heart-drugs2022-11-14T05:20:29+00:00https://www.rsc.org/events/detail/74080/7th-rsc-bmcs-sci-symposium-on-ion-channels-as-therapeutic-targets2023-03-28T07:31:08+00:00https://www.metrionbiosciences.com/metrion-webinar-manoj-patel/2022-11-29T17:18:19+00:00https://www.biophysics.org/2023meeting/general-info2023-02-23T09:03:43+00:00https://iccm2022.univ-lille.fr/2022-12-09T16:20:50+00:00https://www.nanion.de/en/company/career.html2022-11-15T05:02:22+00:00https://www.nanion.de/en/company/career.html2022-12-20T18:16:29+00:00https://www.nature.com/naturecareers/job/postdoctoral-associate-weill-cornell-medicine-wcm-cornell-university-7663682022-11-15T04:57:09+00:00https://www.metrionbiosciences.com/scientist-drug-discovery-electrophysiology/2022-12-20T18:16:20+00:00https://www.metrionbiosciences.com/research-technician/2022-12-20T18:15:53+00:00https://sodiumchannelseminars.org/Program-2022-2023/2022-11-29T17:17:51+00:00https://meetings.ls2.ch/ls2-prestige-2022-ion-channels-membrane-transporters2022-11-29T09:33:28+00:00https://www.hopkinsmedicine.org/news/newsroom/news-releases/extracellular-viscosity-linked-to-cancer-spread2022-11-23T11:38:30+00:00https://kriyatherapeutics.com/2022/11/16/kriya-acquires-redpin-therapeutics-adding-neurology-pipeline-to-gene-therapy-portfolio/2022-11-23T13:36:27+00:00https://www.ucl.ac.uk/news/2022/nov/gene-therapy-targeting-overactive-brain-cells-could-treat-neurological-disorders2022-11-23T15:04:58+00:00https://health.au.dk/en/display/artikel/ny-test-kan-hjaelpe-patienter-med-cystisk-fibrose-12022-11-24T16:54:28+00:00https://www.gateneuro.com/wp-content/uploads/2022/06/Gate-Neurosciences-Emerges-from-Stealth-1-1.pdf2022-11-23T15:46:54+00:00https://www.relmada.com/investors/news/press-releases/detail/269/relmada-therapeutics-announces-top-line-results-from-phase2022-11-23T16:01:33+00:00https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-auvelitytm-first-and2022-11-23T16:20:05+00:00https://ir.aptinyx.com/press-releases/news-details/2022/Clinical-Evaluation-of-Aptinyxs-NYX-783-for-Treatment-of-Opioid-Use-Disorder-to-Be-Funded-by-5.6-Million-NIH-Grant/default.aspx2022-11-23T16:34:23+00:00https://www.imperial.ac.uk/news/241413/scientists-uncover-potential-electrical-language-breast/2022-11-26T14:04:23+00:00https://www.gateneuro.com/wp-content/uploads/2022/11/Gate-Apimostinel-First-Dose-Biomarker-Study.pdf2022-11-29T18:20:28+00:00https://www.sodiumchannelseminars.org/Program-2022-2023/2022-12-14T07:23:25+00:00https://www.sgp2023.com/2023-10-31T22:51:30+00:00https://channelopathy2024.org/2023-04-14T09:47:38+00:00https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-advance-prax-562-phase-2-study2022-11-30T07:16:48+00:00https://www.metrionbiosciences.com/metrion-biosciences-strengthens-global-business-development-team/2022-11-30T16:13:46+00:00https://www.chop.edu/news/chop-researchers-discover-genetic-variant-associated-earlier-onset-childhood-epilepsy2022-12-01T05:26:31+00:00https://investor.stoketherapeutics.com/news-releases/news-release-details/stoke-therapeutics-presents-data-combined-interim-analysis-phase2022-12-05T05:48:22+00:00https://twitter.com/SMRC_Lab/status/15986996591946424322022-12-05T05:53:03+00:00https://www.metrionbiosciences.com/metrion-biosciences-and-the-kcnc1-foundationcollaborate-on-development-of-new-ion-channel-modulatorsfor-ultra-rare-genetic-disorder/2022-12-09T18:31:40+00:00https://seas.harvard.edu/news/2022/12/changing-intrinsic-behavior-neurons2022-12-15T05:33:47+00:00https://myview.uea.ac.uk/webrecruitment/pages/vacancy.jsf?vacancyRef=RA20532022-12-12T03:46:30+00:00https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/169/algernon-pharmaceuticals-receives-u-s-fda-orphan-drug2022-12-12T04:14:33+00:00https://www.relmada.com/investors/news/press-releases/detail/272/relmada-therapeutics-announces-top-line-results-from-phase2022-12-12T04:43:28+00:00https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-presents-new-data-evolve-open-label-trial2022-12-12T05:30:21+00:00https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-axs-05-achieves-primary-endpoint-32022-12-12T05:06:02+00:00https://www.nmdpharma.com/news/ind-clearance-sma-type-32022-12-14T14:25:08+00:00https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-and-ucb-announce-epilepsy-research2022-12-14T14:49:45+00:00https://news.vrtx.com/news-releases/news-release-details/vertex-announces-investigational-new-drug-ind-application-vx-5222022-12-15T05:25:06+00:00https://ir.bionomics.com.au/news-releases/news-release-details/bionomics-reports-topline-results-prevail-phase-2-study-bnc2102022-12-20T15:33:40+00:00https://www.sionnatx.com/press-releases/sionna-therapeutics-announces-ind-clearance-and-phase-1-initiation-for-sion-638-in-cystic-fibrosis/2022-12-20T16:33:41+00:00https://twitter.com/LabPaoletti/status/16049466152443248652022-12-20T18:15:02+00:00https://www.prnewswire.com/news-releases/gilgamesh-pharmaceuticals-raises-39-million-series-b-to-advance-mental-health-treatments-301704097.html2022-12-20T21:27:59+00:00https://ir.catalystpharma.com/news-releases/news-release-details/catalyst-pharmaceuticals-acquire-us-commercial-rights-fycompar2022-12-20T21:37:30+00:00https://quralis.com/quralis-announces-first-in-human-dose-in-phase-1-clinical-trial-of-qrl-101-a-first-in-class-kv7-precision-therapy-for-als/2023-01-06T11:21:39+00:00https://www.ionchannellibrary.com/interviews/engineering-and-reverse-engineering-ion-channels-with-henry-colecraft/2023-03-22T14:00:15+00:00https://www.sbdrugdiscovery.com/news-sygnature-press-release.asp2023-01-18T17:04:50+00:00https://www.nalcn2023.org/2023-10-31T22:50:04+00:00https://www.cambridgeionchannelforum.co.uk/2023-05-15T06:10:35+00:00https://sodiumchannelseminars.org/Program-2022-2023/2023-02-01T09:56:49+00:00https://web.cvent.com/event/1633de32-8966-4bd5-a149-9f085dfd07b0/summary2023-10-31T22:48:42+00:00https://investors.karunatx.com/news-releases/news-release-details/karuna-therapeutics-announces-exclusive-global-license-agreement2023-02-03T08:50:03+00:00https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-and-biogen-announce-fda-accepts-filing-new2023-02-07T00:39:44+00:00https://sodiumchannelseminars.org/Links/2023-03-14T11:04:55+00:00https://ictiseminars.com/calendar2023-02-16T08:55:50+00:00https://kv7channelssymposium.org/2023-10-31T22:51:09+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q3-2022/2023-03-21T11:03:33+00:00https://www.ionchannellibrary.com/blog/feed-the-birds-with-chili-peppers/2023-02-16T11:08:07+00:00https://www.ionchannellibrary.com/blog/sweet-trpm5/2023-02-16T11:06:50+00:00https://www.ionchannellibrary.com/blog/why-does-wasabi-burn-the-nose/2023-02-16T11:30:11+00:00https://www.ionchannellibrary.com/blog/the-scent-of-roses-and-the-mighty-nav1-7/2023-02-16T11:35:54+00:00https://www.ionchannellibrary.com/blog/funny-channels/2023-02-16T11:47:55+00:00https://www.ionchannellibrary.com/blog/exciting-channel-nav1-6/2023-02-16T11:55:16+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-q1-2022-review/2023-03-21T11:00:59+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-q2-2022-review/2023-03-21T11:01:52+00:00https://www.ionchannellibrary.com/interviews/chair-of-timothy-syndrome-alliance-tsa-sophie-muir-on-building-awareness-and-helping-researchers-move-cacna1c-research-forward/2023-02-17T15:40:36+00:00https://www.maxiontherapeutics.com/news/maxion-therapeutics-16-million-series-a-to-drive-antibody-development-for-previously-untreatable-ion-channel-and-gpcr-driven-diseases2023-02-17T00:41:33+00:00https://meetings.cshl.edu/courses.aspx?course=C-ION&year=232023-06-21T05:40:03+00:00https://sophion.com/new-webinar-in-march-novel-patch-clamp-assays-to-advance-pain-research/2023-03-14T11:03:24+00:00https://news.flinders.edu.au/blog/2022/12/23/treating-gut-pain-via-a-nobel-prize-winning-receptor/2023-02-23T09:34:31+00:00https://www.ucd.ie/research/news/2023/ucdandimperialcollegefoetaldevelopmentstudyinscienceadvances/body,664946,en.html2023-02-23T09:50:38+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q4-2022/2023-03-21T11:05:24+00:00https://www.ionchannellibrary.com/blog/ion-channels-and-rare-diseases/2023-03-03T18:49:06+00:00https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-announces-topline-results-essential12023-03-07T16:28:41+00:00https://quralis.com/quralis-closes-88-million-series-b-financing-to-advance-precision-medicines-for-neurodegenerative-diseases/2023-03-09T13:23:33+00:00https://www.nrxpharma.com/nrx-pharmaceuticals-announces-close-of-2-9-million-registered-direct-offering/2023-03-14T11:13:28+00:00https://www.acesionpharma.com/post/positive-phase-2-data-from-atrial-fibrillation-clinical-trial-primary-endpoint-met2023-03-14T11:18:05+00:00https://www.nanion.de/news/cardiac-safety-symposium-2023/2023-06-02T06:11:37+00:00https://wexpharma.com/wp-content/uploads/2023/03/News-Release-CINP202-First-Patient-in-Korea-March-21-2023.pdf2023-03-22T19:39:31+00:00https://axalbion.com/2023/03/21/axalbion-promising-presentation/2023-03-22T19:46:53+00:00https://sodiumchannelseminars.org/Links/2023-03-28T14:37:14+00:00https://mymba.mba.ac.uk/ems-event-booking-page/microelectrode-techniques-for-cell-physiology.html2023-10-31T22:49:46+00:00https://www.ionchannellibrary.com/blog/ephaptic-coupling-and-the-magical-channels/2023-03-27T18:31:10+00:00https://www.prnewswire.com/news-releases/nova-research-laboratories-llc-announces-acquisition-of-cipa-lab-301787644.html2023-04-05T07:38:50+00:00https://ir.bellushealth.com/news-releases/news-release-details/bellus-health-announces-positive-results-its-phase-12023-04-07T10:27:08+00:00https://meetings.ls2.ch/physiology-icmt-20232023-10-31T22:50:55+00:00https://www.ionchannellibrary.com/blog/ion-channels-enable-plants-to-outsmart-some-animals/2023-04-11T13:45:40+00:00https://www.ionchannellibrary.com/blog/lysosomal-channel-tmem175-and-parkinsons-disease/2023-04-11T22:01:39+00:00https://leuven2023.calciumsociety.com/2023-04-14T09:47:51+00:00https://www.ionchannellibrary.com/blog/ion-channels-are-the-key-to-a-vampires-hunting-success/2023-04-21T16:19:32+00:00https://www.maxiontherapeutics.com/news/maxion-therapeutics-awarded-2-million-innovate-uk-funding-to-develop-ion-channel-antibodies-for-hard-to-treat-autoimmune-diseases2023-04-20T13:09:45+00:00https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-health/2023-04-20T13:33:23+00:00https://veneno.jp/new-announcement-of-joint-research-agreement-with-sumitomo-pharma-co-ltd-announced/2023-04-21T09:23:30+00:00https://sodiumchannelseminars.org/2023-04-25T14:56:23+00:00https://www.physoc.org/events/membrane-transport-2023-recent-research-into-ion-channels-transporters-and-epithelial-physiology/2023-10-31T22:49:20+00:00https://www.sgp-epic-seminars.com/2023-05-09T12:04:59+00:00https://www.ionchannellibrary.com/blog/rikki-tikki-tavi-and-the-nicotinic-acetylcholine-receptor/2023-04-21T16:18:35+00:00https://cureclcn4.org/cure-clcn4-scientific-conference-2023/2023-06-21T05:40:16+00:00https://sodiumchannelseminars.org/2023-06-02T06:11:21+00:00https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-announces-positive-topline-results2023-05-15T06:21:25+00:00https://www.nanion.de/news/golden-years-of-semi-automated-patch-clamp/2023-06-21T05:39:49+00:00https://www.sgp-epic-seminars.com/2023-06-07T07:29:45+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q1-2023/2023-06-07T07:06:17+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q2-2023/2023-10-24T08:48:53+00:00https://sodiumchannelseminars.org/Sodium-Channel-Conference-2024/2023-11-01T18:28:25+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q3-2023/2024-02-02T17:57:40+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q4-2023/2024-05-21T15:23:15+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q1-2024/2024-05-22T08:14:13+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q2-2024/2024-08-19T21:28:13+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q3-2024/2024-11-21T09:40:47+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q4-2024/2025-02-21T11:25:05+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q1-2025/2025-06-05T22:06:23+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q2-2025/2025-10-22T15:00:33+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q3-2025/2026-07-06T15:32:05+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q4-2025/2026-07-06T15:38:37+00:00https://www.ionchannellibrary.com/expert_opinions/ion-channel-ligands-in-clinical-development-quarterly-review-q1-2026/2026-07-06T15:44:39+00:00